Avita Medical Limited

ASX:AVH ISIN:AU000000AVH4

 Avita Medical Limited (ASX: AVH) is an ASX listed medical device company formed through the merger of Clinical Cell Culture Ltd and Visiomed Group Ltd in February 2008.

Following the merger Avita Medical is now active in the regenerative medicine and respiratory sectors and has three products in the market. For more information about Avita Medical please visit: http://www.avitamedical.com 
 
        

Sprache wählen

News

Australischer Marktbericht, 2. Februar 2011: Fortis Mining (ASX:FMJ) sichert sich strategisches Investment in Hong Kong

🕔2/2/2011 1:30:00 PM 14927

Australischer Marktbericht, 2. Februar 2011 beinhaltet: Fortis Mining Limited (ASX:FMJ) ist eine strategische Partnerschaft mit Grand Concord Investments Limited eingegangen; Peninsula Energy Limited (ASX:PEN) berichtet von einer 33Mlbs U308 Ressource in den USA; Molopo Energy Limited (ASX:MPO) verkauft Spearfish Öl-Asset an Legacy Oil + Gas Inc (TSE:LEG); Avita Medical Limited (ASX:AVH) hat eine ISO Qualitätszertifizierung abgeschlossen um seine Produkte am europäischen Markt zu verkaufen.

Lesen Sie die komplette Artikel▸
###

146,709 COMPANY PROFILE VIEWS

  • Diese Seite wurde besucht: (letzten 7 Tagen: 23) (letzten 30 Tagen: 135) (seit Veröffentlichung: 13062) 

Company Data

    Headquarters
  • Unit B1, Beech House, Melbourn Science Park
    Cambridge Road
    Melbourn, Royston HERTS SG8 6HB
    United Kingdom
    • Telephone
  • +44-1763-269770 
    • Fax
  • +44-1763-269780 
    • Principal Sector
  • Gesundheit & Pharm 
    • Principal Industry
  • Biotechnology 
    • Homepage
  • www.avitamedical.com

More News Results

  • 2025/10/17: AVITA Medical Announces CEO Transition*
  • 2025/10/03: Statement of CDIs on issue - AVH*
  • 2025/10/02: CMS New Technology Add-On Payment Expands Access to RECELL*
  • 2025/10/01: Notification of cessation of securities - AVH*
  • 2025/09/15: AVITA Medical Receives CE Mark for RECELL GO*
  • 2025/09/05: Real-World Data Shows Significant Reduction in Hospital Stay*
  • 2025/09/04: Statement of CDIs on issue - AVH*
  • 2025/09/04: Change of Director's Interest Notice - RM*
  • 2025/09/03: Notification of cessation of securities - AVH*
  • 2025/08/27: Appendix 3Y and correction to notifiable interests - RM*
*refer to company website